Medplus Health [MEDPLUS] vs Strides Pharma [STAR] Detailed Stock Comparison

Medplus Health Services Ltd.

NSE
Loading...

Strides Pharma Science Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Medplus Health Services Ltd. wins in 6 metrics, Strides Pharma Science Ltd. wins in 13 metrics, with 0 ties. Strides Pharma Science Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Medplus Health Services Ltd. Strides Pharma Science Ltd. Better
P/E Ratio (TTM) 52.45 19.26 Strides Pharma Science Ltd.
Price-to-Book Ratio 5.89 3.57 Strides Pharma Science Ltd.
Debt-to-Equity Ratio 64.69 65.79 Medplus Health Services Ltd.
PEG Ratio 1.08 0.11 Strides Pharma Science Ltd.
EV/EBITDA 28.75 12.80 Strides Pharma Science Ltd.
Profit Margin (TTM) 3.17% 10.82% Strides Pharma Science Ltd.
Operating Margin (TTM) 4.76% 15.51% Strides Pharma Science Ltd.
EBITDA Margin (TTM) 4.76% 15.51% Strides Pharma Science Ltd.
Return on Equity 8.64% 138.93% Strides Pharma Science Ltd.
Return on Assets (TTM) 4.47% 59.41% Strides Pharma Science Ltd.
Free Cash Flow (TTM) $4.81B $4.42B Medplus Health Services Ltd.
Dividend Yield N/A 0.74% N/A
1-Year Return 0.15% 19.61% Strides Pharma Science Ltd.
Price-to-Sales Ratio (TTM) 1.66 2.09 Medplus Health Services Ltd.
Enterprise Value $113.73B $108.98B Medplus Health Services Ltd.
EV/Revenue Ratio 1.74 2.31 Medplus Health Services Ltd.
Gross Profit Margin (TTM) 26.16% 61.25% Strides Pharma Science Ltd.
Revenue per Share (TTM) $546 $513 Medplus Health Services Ltd.
Earnings per Share (Diluted) $17.28 $55.51 Strides Pharma Science Ltd.
Beta (Stock Volatility) 0.46 0.26 Strides Pharma Science Ltd.

Medplus Health Services Ltd. vs Strides Pharma Science Ltd. Stock Performance Analysis

Loading Price Chart...

MEDPLUS
STAR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Medplus Health Services Ltd.-1.28%2.21%-8.44%5.44%7.75%7.41%
Strides Pharma Science Ltd.2.82%7.91%-5.93%21.68%24.92%19.09%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Medplus Health Services Ltd.0.15%10.40%-18.04%-18.04%-18.04%-18.04%
Strides Pharma Science Ltd.19.61%162.17%36.49%3.15%222.14%318.10%

Performance & Financial Health Analysis: Medplus Health Services Ltd. vs Strides Pharma Science Ltd.

MetricMEDPLUSSTAR
Market Information
Market Cap i₹108.75B₹98.28B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i203,009306,327
90 Day Avg. Volume i146,815294,978
Last Close₹870.70₹1,085.30
52 Week Range₹732.00 - ₹1,022.20₹768.65 - ₹1,231.00
% from 52W High-14.82%-11.84%
All-Time High₹1,343.00 (Jan 17, 2022)₹1,675.00 (Oct 14, 2024)
% from All-Time High-35.17%-35.21%
Growth Metrics
Quarterly Revenue Growth0.16%0.04%
Quarterly Earnings Growth0.26%1.30%
Financial Health
Profit Margin (TTM) i0.03%0.11%
Operating Margin (TTM) i0.05%0.16%
Return on Equity (TTM) i0.09%1.39%
Debt to Equity (MRQ) i64.6965.79
Cash & Liquidity
Book Value per Share (MRQ)₹153.91₹299.06
Cash per Share (MRQ)₹41.85₹24.68
Operating Cash Flow (TTM) i₹2.69B₹36.02B
Levered Free Cash Flow (TTM) i₹1.50B₹35.93B
Dividends
Last 12-Month Dividend Yield iN/A0.74%
Last 12-Month Dividend iN/A₹6.50

Valuation & Enterprise Metrics Analysis: Medplus Health Services Ltd. vs Strides Pharma Science Ltd.

MetricMEDPLUS (Apr 24, 2026)STAR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i52.4519.26
Forward P/E i44.2414.73
PEG Ratio i1.080.11
Price to Sales (TTM) i1.662.09
Price to Book (MRQ) i5.893.57
Market Capitalization
Market Capitalization i₹108.75B₹98.28B
Enterprise Value i₹113.73B₹108.98B
Enterprise Value Metrics
Enterprise to Revenue i1.742.31
Enterprise to EBITDA i28.7512.80
Risk & Other Metrics
Beta i0.460.26
Book Value per Share (MRQ) i₹153.91₹299.06

Financial Statements Comparison: Medplus Health Services Ltd. vs Strides Pharma Science Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMEDPLUS (2025)STAR (2025)
Revenue/Sales i60.87B43.92B
Cost of Goods Sold i46.41B21.34B
COGS % of Revenue i76.2%48.6%
Gross Profit i14.47B22.58B
Gross Margin i23.8%51.4%
Research & Development iN/AN/A
Operating Income (EBIT) i2.39B5.80B
Operating Margin i3.9%13.2%
EBITDA i5.29B7.90B
EBITDA Margin i8.7%18.0%
Pre-Tax Income i1.83B4.87B
Pre-Tax Income % of Revenue i3.0%11.1%
Income Tax i330.56M775.16M
Income Tax % of Revenue i0.5%1.8%
Net Income (Profit) i1.50B35.98B
Profit Margin i2.5%81.9%

Balance Sheet & Liquidity Metrics

MetricMEDPLUS (2025)STAR (2025)
Cash & Equivalents i860.52M1.13B
Total Current Assets i18.44B31.02B
Total Current Assets % of Revenue i30.3%70.6%
Total Current Liabilities i5.77B25.92B
Total Current Liabilities % of Revenue i9.5%59.0%
Long-Term Debt i10.08B6.23B
Long-Term Debt % of Revenue i16.6%14.2%
Total Shareholders Equity i17.40B25.86B
Retained Earnings i4.30B4.59B
Retained Earnings % of Revenue i7.1%10.4%
Property, Plant & Equipment i12.49B8.81B

Cash Flow Statement Comparison

MetricMEDPLUS (2025)STAR (2025)
Operating Cash Flow i2.69B36.02B
Operating Cash Flow % of Revenue i4.4%82.0%
Capital Expenditures i-584.02M681.03M
Free Cash Flow i4.81B4.42B
FCF Margin i7.9%10.1%
Debt Repayment iN/A-3.20B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricMEDPLUSSTAR
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i120.00M92.17M
Float Shares i69.60M56.69M
% Held by Insiders i41.74%30.78%
% Held by Institutions i35.32%26.99%
% Held by Public i22.94%42.23%

Dividend Analysis & Yield Comparison: Medplus Health Services Ltd. vs Strides Pharma Science Ltd.

MetricMEDPLUSSTAR
Last 12-Month Dividend iN/A₹6.50
Last 12-Month Dividend Yield iN/A0.74%
3-Year Avg Annual Dividend iN/A₹2.67
3-Year Avg Dividend Yield iN/A0.32%
3-Year Total Dividends iN/A₹8.00
Ex-Dividend DateN/AJul 22, 2025